Carnitine palmitoyltransferase II (CPT2) or carnitine deficiency should be considered in treatment refractory migraine
The FDA approves specific finished drug products, such as: Ozempic (semaglutide injection for diabetes) Wegovy (semaglutide injection for weight management) Mounjaro (tirzepatide injection for diabetes) Zepbound (tirzepatide injection for weight management) Compounded medications: Are not FDA approved, even if they use an FDA-approved ingredient or the same API Do not undergo the same large, branded clinical trials as commercial products Are regulated differentlythrough oversight of the pharmacys practices, not approval of each batch as a drug product This does not automatically mean they are unsafe, but it does mean that pharmacy quality is critical
Some of the common causes of hyperpigmentation include: Sun exposure: UV rays stimulate melanin production, leading to sun spots or age spots
After reviewing comments, the FDA will issue a final determination
This anti-apoptotic activity in lymphoid tissue contributes to preservation of immune system capacity during aging and environmental challenges
Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s